About: Low gene expression of TNF, IL17A, IL23A, and IL12B in tumors: a safety surrogate to predict cancer survival associated with biologic therapies

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Low gene expression of TNF, IL17A, IL23A, and IL12B in tumors: a safety surrogate to predict cancer survival associated with biologic therapies Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Low gene expression of TNF, IL17A, IL23A, and IL12B in tumors: a safety surrogate to predict cancer survival associated with biologic therapies
Creator	Gupta, Sameer Merola, Joseph Gottlieb, Alice Klebanov, Nikolai Mphil, M Perez-Chada, Lourdes
Source	PMC
abstract	covid:fb73bb354ccd0eb384511d03fd76e944bbc9f27a#abstract
has issue date	2020-08-18(xsd:dateTime)
bibo:doi	10.1016/j.jaad.2020.08.050
has license	no-cc
sha1sum (hex)	fb73bb354ccd0eb384511d03fd76e944bbc9f27a
schema:url	https://doi.org/10.1016/j.jaad.2020.08.050
resource representing a document's title	Low gene expression of TNF, IL17A, IL23A, and IL12B in tumors: a safety surrogate to predict cancer survival associated with biologic therapies
has PubMed Central identifier	PMC7434493
schema:publication	J Am Acad Dermatol
resource representing a document's body	covid:fb73bb354ccd0eb384511d03fd76e944bbc9f27a#body_text
is schema:about of	named entity 'psoriasis' named entity 'expression' named entity 'ACTIVE' named entity 'MALIGNANCY' named entity 'IL17' named entity 'IL17A' named entity 'hazards models' named entity 'malignancies' named entity 'proportional hazards' named entity 'TNF' named entity 'risk' named entity 'gene expression data' named entity 'receive' named entity 'predict' named entity 'biologics' named entity 'malignancy' named entity 'IL12' named entity 'psoriasis' named entity 'psoriasis' named entity 'TNF' named entity 'biologic therapies' named entity 'IL12B' named entity 'IL23A' named entity 'IL23A' named entity 'Genome' named entity 'RNA-Seq' named entity 'IL12B' named entity 'malignancy' named entity 'clinical data' named entity 'percentile' named entity 'tumor' named entity 'tumor stage' named entity 'TCGA' named entity 'malignancies' named entity 'malignancies' named entity 'multiple testing' named entity 'biologic therapy' named entity 'false discovery rate' named entity 'tumors' named entity 'IL12B' named entity 'TNF' named entity 'IL23A' named entity 'TNF' named entity 'immune' named entity 'biologics' named entity 'IL17A' named entity 'gene expression' named entity 'COMPATIBILITY' named entity 'SURVIVAL' named entity 'CANCER' named entity 'SAFETY' named entity 'TUMORS' named entity 'JOURNAL ' named entity 'TABLES' named entity 'IMMUNE' named entity 'PATHWAY' named entity 'PSORIASIS' named entity 'IL17' named entity 'biologics' named entity 'biologic therapies' named entity 'tumors' named entity 'TNF' named entity 'IL17A' named entity 'DID' named entity 'RECEIVE' named entity 'FUNDING SOURCES' named entity 'IL12' named entity 'FUNDING' named entity 'BIOLOGIC THERAPIES' named entity 'biologics' named entity 'biologics' named entity 'malignancy' named entity 'BIOLOGICS' named entity 'TNF' named entity 'IL23' named entity 'IL12' named entity 'gene expression' named entity 'cancer'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software